Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Prostatectomy & nephrectomy · Florida | Prostatectomy & nephrectomy · Texas | |
|---|---|---|
| Surgeons, 2024 | 36 | 41 |
| Medicare fee-for-service cases | 2,306 | 2,404 |
| Growth since 2019 (Medicare FFS) | +0.2%/yr | −0.5%/yr |
| Forecast cases (Medicare FFS) | 2,680 in 2030 | 3,280 in 2030 |
| Forecast growth | +2.5%/yr to 2030 | +5.3%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.1 | 1.2 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 64 | 59 |
| Top 10 surgeons' share | 60% | 49% |
| Surgeons growing | 2 | 2 |
| New since the base year | 5 | 1 |
| Likely to stop billing it | 8 by 2026 | 12 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $21K | $16K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.